
Swiss Pharma Contract is a CRO based in Switzerland providing services in Clinical Pharmacology and Clinical Research. Swiss Pharma Contract runs Phase I, and other human pharmacology studies in its own Clinical Unit, as well as phase II, phase III and phase IV studies in a European network together with renowned study centers.
Your benefits:
Speed: in the region of Basle, phase I, phase IIa, and ADME studies are greatly accelerated by the absence of unnecessary regulatory hurdles. . (E.g. from submission to the ethics committee to first administration into man in only three weeks).
Quality: Swiss Pharma Contract has been successfully audited by major pharmaceutical companies. Studies are conducted under GCP and GLP conditions and according to international ICH guidelines.
Experience: studies are directed by three senior physicians with a strong experience acquired in major pharmaceutical, contract research, or public organizations. Swiss Pharma Contract takes advantage of the outstanding know-how of the Basle area.
Our Services:
Clinical Pharmacology
(E.g. Phase I, ADME, Bioequivalence Studies, Drug - Drug Interaction Studies, Pharmacokinetic and Pharmacodynamic Studies in Healthy Subjects and Patients)
Clinical Research
(Phase II, Phase III, and Phase IV, Anwendungsbeobachtungen)
Own Clinical Unit with 24 beds
Data Management, Pharmacokinetics and Statistics
Consulting
clinical pharmacology, clinical research, clinical trials, human pharmacology, ADME, phase I, phase 1, CRO switzerland, bioequivalence, pharmacokinetic, pharmacodynamic, drug-drug interaction, food interaction, anwendungsbeobachtung, pass, life cycle management, cross over study, post marketing, contract research organization, CRF, GCP, data management, scientific consulting, biometric, statistic, pharmacology, proof of concept, proof of principle, ICH guidelines, patient, healthy subject, volunteer, probanten, basle, switzerland, biovalley, bioavailability